About this Journal Submit a Manuscript Table of Contents
Oxidative Medicine and Cellular Longevity
Volume 2013 (2013), Article ID 575482, 15 pages
http://dx.doi.org/10.1155/2013/575482
Review Article

A Review of Pterostilbene Antioxidant Activity and Disease Modification

1Mailman School of Public Health, Columbia University, Allan Rosenfield Building, 722 West 168th Street, New York, NY 10032, USA
2Department of Surgery, University of Connecticut Health Center, 263 Farmington Avenue, Farmington, CT 06030, USA

Received 13 February 2013; Accepted 18 March 2013

Academic Editor: Nilanjana Maulik

Copyright © 2013 Denise McCormack and David McFadden. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. A. Roupe, C. M. Remsberg, J. A. Yáñez, and N. M. Davies, “Pharmacometrics of stilbenes: seguing towards the clinic,” Current clinical pharmacology, vol. 1, no. 1, pp. 81–101, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. H. S. Lin, B. D. Yue, and P. C. Ho, “Determination of pterostilbene in rat plasma by a simple HPLC-UV method and its application in pre-clinical pharmacokinetic study,” Biomedical Chromatography, vol. 23, no. 12, pp. 1308–1315, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. A. M. Rimando, W. Kalt, J. B. Magee, J. Dewey, and J. R. Ballington, “Resveratrol, pterostilbene, and piceatannol in Vaccinium berries,” Journal of Agricultural and Food Chemistry, vol. 52, no. 15, pp. 4713–4719, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Rodríguez-Bonilla, J. M. López-Nicolás, and L. Méndez-Cazorla, “Development of a reversed phase high performance liquid chromatography method based on the use of cyclodextrins as mobile phase additives to determine pterostilbene in blueberries,” Journal of Chromatography B, vol. 879, no. 15-16, pp. 1091–1197, 2011.
  5. D. McCormack and D. McFadden, “Pterostilbene and cancer: current review,” Journal of Surgical Research, vol. 173, no. 2, pp. 53–61, 2012.
  6. I. M. Kapetanovic, M. Muzzio, Z. Huang, et al., “Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats,” Cancer Chemotherapy and Pharmacology, vol. 68, no. 3, pp. 593–601, 2011.
  7. T. Perecko, K. Drabikova, L. Rackova, and M. Ciz, “Molecular targets of the natural antioxidant pterostilbene: effect on protein kinase C, caspase-3 and apoptosis in human neutrophils in vitro,” Neuroendocrinology Letters, vol. 31, no. 2, pp. 84–90, 2010.
  8. L. A. Stivala, M. Savio, F. Carafoli et al., “Specific structural determinants are responsible for the antioxidant activity and the cell cycle effects of resveratrol,” The Journal of Biological Chemistry, vol. 276, no. 25, pp. 22586–22594, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Athar, J. H. Back, X. Tang et al., “Resveratrol: a review of preclinical studies for human cancer prevention,” Toxicology and Applied Pharmacology, vol. 224, no. 3, pp. 274–283, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Bishayee, “Cancer prevention and treatment with resveratrol: from rodent studies to clinical trials,” Cancer Prevention Research, vol. 2, no. 5, pp. 409–418, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. A. M. Rimando, M. Cuendet, C. Desmarchelier, R. G. Mehta, J. M. Pezzuto, and S. O. Duke, “Cancer chemopreventive and antioxidant activities of pterostilbene, a naturally occurring analogue of resveratrol,” Journal of Agricultural and Food Chemistry, vol. 50, no. 12, pp. 3453–3457, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. C. M. Remsberg, J. A. Yáñez, Y. Ohgami, K. R. Vega-Villa, A. M. Rimando, and N. M. Davies, “Pharmacometrics of pterostilbene: preclinical pharmacokinetics and metabolism, anticancer, antiinflammatory, antioxidant and analgesic activity,” Phytotherapy Research, vol. 22, no. 2, pp. 169–179, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. A. A. M. Adly, “Oxidative stress and disease: an updated review,” Research Journal of Immunology, vol. 3, no. 2, pp. 129–145, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. C. L. Rock, T. E. Byers, G. A. Colditz, et al., “Reducing breast cancer recurrence with weight loss, a vanguard trial: the Exercise and Nutrition to Enhance Recovery and Good Health for You (ENERGY) Trial,” Contemporary Clinical Trials, vol. 34, no. 2, pp. 282–295, 2013.
  15. X. Wu, O. Rahal, J. Kang, S. R. Till, R. L. Prior, and R. C. M. Simmen, “In utero and lactational exposure to blueberry via maternal diet promotes mammary epithelial differentiation in prepubescent female rats,” Nutrition Research, vol. 29, no. 11, pp. 802–811, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. N. P. Seeram, L. S. Adams, Y. Zhang et al., “Blackberry, black raspberry, blueberry, cranberry, red raspberry, and strawberry extracts inhibit growth and stimulate apoptosis of human cancer cells in vitro,” Journal of Agricultural and Food Chemistry, vol. 54, no. 25, pp. 9329–9339, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. D. Boivin, M. Blanchette, S. Barrette, A. Moghrabi, and R. Béliveau, “Inhibition of cancer cell proliferation and suppression of TNF-induced activation of NFκB by edible berry juice,” Anticancer Research, vol. 27, no. 2, pp. 937–948, 2007. View at Scopus
  18. L. S. Adams, N. Kanaya, S. Phung, Z. Liu, and S. Chen, “Whole blueberry powder modulates the growth and metastasis of MDA-MB-231 triple negative breast tumors in nude mice,” Journal of Nutrition, vol. 141, no. 10, pp. 1805–1812, 2011.
  19. J. A. Alosi, D. E. McDonald, J. S. Schneider, A. R. Privette, and D. W. McFadden, “Pterostilbene inhibits breast cancer in vitro through mitochondrial depolarization and induction of caspase-dependent apoptosis,” Journal of Surgical Research, vol. 161, no. 2, pp. 195–201, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Mannal, D. McDonald, and D. McFadden, “Pterostilbene and tamoxifen show an additive effect against breast cancer in vitro,” American Journal of Surgery, vol. 200, no. 5, pp. 577–580, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Chakraborty, N. Gupta, K. Ghosh, and P. Roy, “In vitro evaluation of the cytotoxic, anti-proliferative and anti-oxidant properties of pterostilbene isolated from Pterocarpus marsupium,” Toxicology in Vitro, vol. 24, no. 4, pp. 1215–1228, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Chakraborty, N. Bodipati, M. K. Demonacos, et al., “Long term induction by pterostilbene results in autophagy and cellular differentiation in MCF-7 cells via ROS dependent pathway,” Molecular and Cellular Endocrinology, vol. 355, no. 1, pp. 25–40, 2012.
  23. D. Moon, D. McCormack, D. McDonald, and D. McFadden, “Pterostilbene induces mitochondrially derived apoptosis in breast cancer cells in vitro,” Journal of Surgical Research, vol. 180, no. 2, pp. 208–215, 2013.
  24. M. J. Hitchler, K. Wikainapakul, L. Yu, K. Powers, W. Attatippaholkun, and F. E. Domann, “Epigenetic regulation of manganese superoxide dismutase expression in human breast cancer cells,” Epigenetics, vol. 1, no. 4, pp. 163–171, 2006. View at Scopus
  25. Y. Soini, M. Vakkala, K. Kahlos, P. Pääkkö, and V. Kinnula, “MnSOD expression is less frequent in tumour cells of invasive breast carcinomas than in in situ carcinomas or non-neoplastic breast epithelial cells,” The Journal of Pathology, vol. 195, no. 2, pp. 156–162, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. J. J. Li, L. W. Oberley, D. K. St Clair, L. A. Ridnour, and T. D. Oberley, “Phenotypic changes induced in human breast cancer cells by overexpression of manganese-containing superoxide dismutase,” Oncogene, vol. 10, no. 10, pp. 1989–2000, 1995. View at Scopus
  27. C. D. Fryar, T. Chen, and X. Li, “Prevalence of uncontrolled risk factors for cardiovascular disease: United States, 1999–2010,” NCHS Data Brief 103, National Center for Health Statistics, Hyattsville, Md, USA, 2012.
  28. J. A. Leopold and J. Loscalzo, “Oxidative enzymopathies and vascular disease—ATVB in focus,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 7, pp. 1332–1340, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. C. C. Neto, “Cranberry and blueberry: evidence for protective effects against cancer and vascular diseases,” Molecular Nutrition and Food Research, vol. 51, no. 6, pp. 652–664, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. I. Ahmet, E. Spangler, B. Shukitt-Hale et al., “Blueberry-enriched diet protects rat heart from ischemic damage,” PLoS ONE, vol. 4, no. 6, Article ID e5954, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. X. Wu, J. Kang, C. Xie et al., “Dietary blueberries attenuate atherosclerosis in apolipoprotein E-deficient mice by upregulating antioxidant enzyme expression,” Journal of Nutrition, vol. 140, no. 9, pp. 1628–1632, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. K. A. Youdim, J. McDonald, W. Kalt, and J. A. Joseph, “Potential role of dietary flavonoids in reducing microvascular endothelium vulnerability to oxidative and inflammatory insults,” The Journal of Nutritional Biochemistry, vol. 13, no. 5, pp. 282–288, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. E. S. Park, Y. Lim, J. T. Hong et al., “Pterostilbene, a natural dimethylated analog of resveratrol, inhibits rat aortic vascular smooth muscle cell proliferation by blocking Akt-dependent pathway,” Vascular Pharmacology, vol. 53, no. 1-2, pp. 61–67, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. L. Zhang, G. Zhou, W. Song, et al., “Pterostilbene protects vascular endothelial cells against oxidized low-density lipoprotein-induced apoptosis in vitro and in vivo,” Apoptosis, vol. 17, no. 1, pp. 25–36, 2012.
  35. L. Zhang, L. Cui, G. Zhou, et al., “Pterostilbene, a natural small-molecular compound, promotes cytoprotective macroautophagy in vascular endothelial cells,” The Journal of Nutritional Biochemistry. In press.
  36. Y. L. Zhang, Y. J. Cao, X. Zhang et al., “The autophagy-lysosome pathway: a novel mechanism involved in the processing of oxidized LDL in human vascular endothelial cells,” Biochemical and Biophysical Research Communications, vol. 394, no. 2, pp. 377–382, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Aoki, T. Nata, R. Morishita et al., “Endothelial apoptosis induced by oxidative stress through activation of NF-κB: antiapoptotic effect of antioxidant agents on endothelial cells,” Hypertension, vol. 38, no. 1, pp. 48–55, 2001. View at Scopus
  38. S. Xu, S. Ogura, J. Chen, et al., “LOX-1 in atherosclerosis: biological functions and pharmacological modifiers,” Cellular and Molecular Life Sciences. In press.
  39. S. R. McAnulty, L. S. McAnulty, J. D. Morrow et al., “Effect of daily fruit ingestion on angiotensin converting enzyme activity, blood pressure, and oxidative stress in chronic smokers,” Free Radical Research, vol. 39, no. 11, pp. 1241–1248, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. P. C. Enzinger and R. J. Mayer, “Esophageal cancer,” The New England Journal of Medicine, vol. 349, no. 23, pp. 2241–2252, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. G. D. Stoner, L. S. Wang, C. Seguin et al., “Multiple berry types prevent N-nitrosomethylbenzylamine-induced esophageal cancer in rats,” Pharmaceutical Research, vol. 27, no. 6, pp. 1138–1145, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. H. H. Hartgrink, E. P. Jansen, N. C. van Grieken, and C. J. van de Velde, “Gastric cancer,” The Lancet, vol. 374, no. 9688, pp. 477–490, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. M. H. Pan, Y. H. Chang, V. Badmaev, K. Nagabhushanam, and C. T. Ho, “Pterostilbene induces apoptosis and cell cycle arrest in human gastric carcinoma cells,” Journal of Agricultural and Food Chemistry, vol. 55, no. 19, pp. 7777–7785, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. T. A. Ullman and S. H. Itzkowitz, “Intestinal inflammation and cancer,” Gastroenterology, vol. 140, no. 6, pp. 1807–1816, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. A. M. Rimando and N. Suh, “Biological/chemopreventive activity of stilbenes and their effect on colon cancer,” Planta Medica, vol. 74, no. 13, pp. 1635–1643, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. N. Suh, S. Paul, X. Hao et al., “Pterostilbene, an active constituent of blueberries, suppresses aberrant crypt foci formation in the azoxymethane-induced colon carcinogenesis model in rats,” Clinical Cancer Research, vol. 13, no. 1, pp. 350–355, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. Y. S. Chiou, M. L. Tsai, K. Nagabhushanam et al., “Pterostilbene is more potent than resveratrol in preventing azoxymethane (AOM)-induced colon tumorigenesis via activation of the NF-E2-related factor 2 (Nrf2)-mediated antioxidant signaling pathway,” Journal of Agricultural and Food Chemistry, vol. 59, no. 6, pp. 2725–2733, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. S. Priego, F. Feddi, P. Ferrer et al., “Natural polyphenols facilitate elimination of HT-29 colorectal cancer xenografts by chemoradiotherapy: a Bcl-2- and superoxide dismutase 2-dependent mechanism,” Molecular Cancer Therapeutics, vol. 7, no. 10, pp. 3330–3342, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. E. A. Hileman, G. Achanta, and P. Huang, “Superoxide dismutase: an emerging target for cancer therapeutics,” Expert Opinion on Therapeutic Targets, vol. 5, no. 6, pp. 697–710, 2001. View at Scopus
  50. G. Dhaliwal, P. A. Cornett, and L. M. Tierney Jr., “Hemolytic anemia,” American Family Physician, vol. 69, no. 11, pp. 2599–2606, 2004. View at Scopus
  51. K. A. Youdim, B. Shukitt-Hale, S. MacKinnon, W. Kalt, and J. A. Joseph, “Polyphenolics enhance red blood cell resistance to oxidative stress: in vitro and in vivo,” Biochimica et Biophysica Acta, vol. 1523, no. 1, pp. 117–122, 2000. View at Publisher · View at Google Scholar · View at Scopus
  52. R. Mikstacka, A. M. Rimando, and E. Ignatowicz, “Antioxidant effect of trans-resveratrol, pterostilbene, quercetin and their combinations in human erythrocytes in vitro,” Plant Foods for Human Nutrition, vol. 65, no. 1, pp. 57–63, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. J. Stocks and T. L. Dormandy, “The autoxidation of human red cell lipids induced by hydrogen peroxide,” British Journal of Haematology, vol. 20, no. 1, pp. 95–111, 1971. View at Scopus
  54. M. Parola and G. Robino, “Oxidative stress-related molecules and liver fibrosis,” Journal of Hepatology, vol. 35, no. 2, pp. 297–306, 2001. View at Publisher · View at Google Scholar · View at Scopus
  55. Y. P. Wang, M. L. Cheng, B. F. Zhang, M. Mu, and J. Wu, “Effects of blueberry on hepatic fbrosis and transcription factor Nrf2 in rats,” World Journal of Gastroenterology, vol. 16, no. 21, pp. 2657–2663, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. Y. P. Wang, M. L. Cheng, B. F. Zhang et al., “Effect of blueberry on hepatic and immunological functions in mice,” Hepatobiliary and Pancreatic Diseases International, vol. 9, no. 2, pp. 164–168, 2010. View at Scopus
  57. N. Osman, D. Adawi, S. Ahrné, B. Jeppsson, and G. Molin, “Endotoxin- and d-galactosamine-induced liver injury improved by the administration of Lactobacillus, Bifidobacterium and blueberry,” Digestive and Liver Disease, vol. 39, no. 9, pp. 849–856, 2007. View at Publisher · View at Google Scholar · View at Scopus
  58. B. M. Schmidt, A. B. Howell, B. McEniry et al., “Effective separation of potent antiproliferation and antiadhesion components from wild blueberry (Vaccinium angustifolium Ait.) fruits,” Journal of Agricultural and Food Chemistry, vol. 52, no. 21, pp. 6433–6442, 2004. View at Publisher · View at Google Scholar · View at Scopus
  59. J. S. Kim, T. Y. Ha, J. Ahn, H. K. Kim, and S. Kim, “Pterostilbene from Vitis coignetiae protect H2O2-induced inhibition of gap junctional intercellular communication in rat liver cell line,” Food and Chemical Toxicology, vol. 47, no. 2, pp. 404–409, 2009. View at Publisher · View at Google Scholar · View at Scopus
  60. A. H. Hasiah, A. R. Ghazali, J. F. F. Weber, S. Velu, N. F. Thomas, and S. H. Inayat Hussain, “Cytotoxic and antioxidant effects of methoxylated stilbene analogues on HepG2 hepatoma and Chang liver cells: implications for structure activity relationship,” Human and Experimental Toxicology, vol. 30, no. 2, pp. 138–144, 2011. View at Publisher · View at Google Scholar · View at Scopus
  61. M. H. Pan, Y. S. Chiou, W. J. Chen, J. M. Wang, V. Badmaev, and C. T. Ho, “Pterostilbene inhibited tumor invasion via suppressing multiple signal transduction pathways in human hepatocellular carcinoma cells,” Carcinogenesis, vol. 30, no. 7, pp. 1234–1242, 2009. View at Publisher · View at Google Scholar · View at Scopus
  62. C. Sharma, K. Eltawil, P. Renfrew, et al., “Advances in diagnosis, treatment and palliation of pancreatic clinical carcinoma: 1990–2010,” World Journal of Gastroenterology, vol. 17, no. 7, pp. 867–987, 2011.
  63. P. W. Mannal, J. A. Alosi, J. G. Schneider, D. E. McDonald, and D. W. McFadden, “Pterostilbene inhibits pancreatic cancer in vitro,” Journal of Gastrointestinal Surgery, vol. 14, no. 5, pp. 873–879, 2010. View at Publisher · View at Google Scholar · View at Scopus
  64. D. E. McCormack, P. Mannal, D. McDonald, et al., “Genomic analysis of pterostilbene predicts its antiproliferative effects against pancreatic cancer in vitro and in vivo,” Journal of Gastrointestinal Surgery, vol. 16, no. 6, pp. 1136–1143, 2012.
  65. C. Weydert, B. Roling, J. Liu et al., “Suppression of the malignant phenotype in human pancreatic cancer cells by the overexpression of manganese superoxide dismutase,” Molecular Cancer Therapeutics, vol. 2, no. 4, pp. 361–369, 2003. View at Scopus
  66. E. M. Hurt, S. B. Thomas, B. Peng, and W. L. Farrar, “Molecular consequences of SOD2 expression in epigenetically silenced pancreatic carcinoma cell lines,” British Journal of Cancer, vol. 97, no. 8, pp. 1116–1123, 2007. View at Publisher · View at Google Scholar · View at Scopus
  67. M. Ough, A. Lewis, Y. Zhang et al., “Inhibition of cell growth by overexpression of manganese superoxide dismutase (MnSOD) in human pancreatic carcinoma,” Free Radical Research, vol. 38, no. 11, pp. 1223–1233, 2004. View at Publisher · View at Google Scholar · View at Scopus
  68. J. J. Cullen, C. Weydert, M. M. Hinkhouse et al., “The role of manganese superoxide dismutase in the growth of pancreatic adenocarcinoma,” Cancer Research, vol. 63, no. 6, pp. 1297–1303, 2003. View at Scopus
  69. S. F. Kostin, D. E. McDonald, and D. W. McFadden, “Inhibitory effects of (-)-epigallocatechin-3-gallate and pterostilbene on pancreatic cancer growth in vitro,” Journal of Surgical Research, vol. 177, no. 2, pp. 255–262, 2012.
  70. D. McCormack, D. McDonald, and D. McFadden, “Pterostilbene ameliorates tumor necrosis factor alpha-induced pancreatitis in vitro,” Journal of Surgical Research, vol. 178, no. 1, pp. 28–32, 2012.
  71. C. J. Nolan, P. Damm, and M. Prentki, “Type 2 diabetes across generations: from pathophysiology to prevention and management,” The Lancet, vol. 378, no. 9786, pp. 169–181, 2011. View at Publisher · View at Google Scholar · View at Scopus
  72. D. M. Nguyen and H. B. El-Serag, “The epidemiology of obesity,” Gastroenterology Clinics of North America, vol. 39, no. 1, pp. 1–7, 2010. View at Publisher · View at Google Scholar · View at Scopus
  73. J. K. Grover, V. Vats, and S. S. Yadav, “Pterocarpus marsupium extract (Vijayasar) prevented the alteration in metabolic patterns induced in the normal rat by feeding an adequate diet containing fructose as sole carbohydrate,” Diabetes, Obesity and Metabolism, vol. 7, no. 4, pp. 414–420, 2005. View at Publisher · View at Google Scholar · View at Scopus
  74. M. Manickam, M. Ramanathan, M. A. Farboodniay Jahromi, J. P. N. Chansouria, and A. B. Ray, “Antihyperglycemic activity of phenolics from Pterocarpus marsupium,” Journal of Natural Products, vol. 60, no. 6, pp. 609–610, 1997. View at Publisher · View at Google Scholar · View at Scopus
  75. L. Pari and M. A. Satheesh, “Effect of pterostilbene on hepatic key enzymes of glucose metabolism in streptozotocin- and nicotinamide-induced diabetic rats,” Life Sciences, vol. 79, no. 7, pp. 641–645, 2006. View at Publisher · View at Google Scholar · View at Scopus
  76. M. A. Satheesh and L. Pari, “The antioxidant role of pterostilbene in streptozotocin-nicotinamide-induced type 2 diabetes mellitus in Wistar rats,” Journal of Pharmacy and Pharmacology, vol. 58, no. 11, pp. 1483–1490, 2006. View at Publisher · View at Google Scholar · View at Scopus
  77. E. Nemes-Nagy, T. Szocs-Molnár, I. Dunca, et al., “Effect of a dietary supplement containing blueberry and sea buckthorn concentrate on antioxidant capacity in type 1 diabetic children,” Acta Physiologica Hungarica, vol. 95, no. 4, pp. 383–393, 2008. View at Publisher · View at Google Scholar · View at Scopus
  78. C. L. Hsu, Y. J. Lin, C. T. Ho, et al., “Inhibitory effects of garcinol and pterostilbene on cell proliferation and adipogenesis in 3T3-L1 cells,” Food & Function, vol. 3, no. 1, pp. 49–57, 2012.
  79. A. M. Rimando, R. Nagmani, D. R. Feller, and W. Yokoyama, “Pterostilbene, a new agonist for the peroxisome proliferator-activated receptor α-isoform, lowers plasma lipoproteins and cholesterol in hypercholesterolemic hamsters,” Journal of Agricultural and Food Chemistry, vol. 53, no. 9, pp. 3403–3407, 2005. View at Publisher · View at Google Scholar · View at Scopus
  80. M. Citron, “Alzheimer's disease: strategies for disease modification,” Nature Reviews Drug Discovery, vol. 9, no. 5, pp. 387–398, 2010. View at Publisher · View at Google Scholar · View at Scopus
  81. Y. Christen, “Oxidative stress and Alzheimer disease,” The American Journal of Clinical Nutrition, vol. 71, supplement 2, pp. 621S–629S, 2000.
  82. A. Nunomura, R. J. Castellani, X. Zhu, P. I. Moreira, G. Perry, and M. A. Smith, “Involvement of oxidative stress in Alzheimer disease,” Journal of Neuropathology and Experimental Neurology, vol. 65, no. 7, pp. 631–641, 2006. View at Publisher · View at Google Scholar · View at Scopus
  83. J. A. Joseph, D. R. Fisher, V. Cheng, A. M. Rimando, and B. Shukitt-Hale, “Cellular and behavioral effects of stilbene resveratrol analogues: implications for reducing the deleterious effects of aging,” Journal of Agricultural and Food Chemistry, vol. 56, no. 22, pp. 10544–10551, 2008. View at Publisher · View at Google Scholar · View at Scopus
  84. J. A. Joseph, G. Arendash, M. Gordon, et al., “Blueberry supplementation enhances signaling and prevents behavioral deficits in an Alzheimer disease model,” Nutritional Neuroscience, vol. 6, no. 3, pp. 153–162, 2003. View at Publisher · View at Google Scholar · View at Scopus
  85. J. A. Joseph, D. R. Fisher, and D. Bielinski, “Blueberry extract alters oxidative stress-mediated signaling in COS-7 cells transfected with selectively vulnerable muscarinic receptor subtypes,” Journal of Alzheimer's Disease, vol. 9, no. 1, pp. 35–42, 2006. View at Scopus
  86. P. C. Bickford, T. Gould, L. Briederick et al., “Antioxidant-rich diets improve cerebellar physiology and motor learning in aged rats,” Brain Research, vol. 866, no. 1-2, pp. 211–217, 2000. View at Publisher · View at Google Scholar · View at Scopus
  87. D. H. Malin, D. R. Lee, P. Goyarzu et al., “Short-term blueberry-enriched diet prevents and reverses object recognition memory loss in aging rats,” Nutrition, vol. 27, no. 3, pp. 338–342, 2011. View at Publisher · View at Google Scholar · View at Scopus
  88. C. Andres-Lacueva, B. Shukitt-Hale, R. L. Galli, O. Jauregui, R. M. Lamuela-Raventos, and J. A. Joseph, “Anthocyanins in aged blueberry-fed rats are found centrally and may enhance memory,” Nutritional Neuroscience, vol. 8, no. 2, pp. 111–120, 2005. View at Publisher · View at Google Scholar · View at Scopus
  89. G. Casadesus, B. Shukitt-Hale, H. M. Stellwagen et al., “Modulation of hippocampal plasticity and cognitive behavior by short-term blueberry supplementation in aged rats,” Nutritional Neuroscience, vol. 7, no. 5-6, pp. 309–316, 2004. View at Publisher · View at Google Scholar · View at Scopus
  90. M. I. Sweeney, W. Kalt, S. L. MacKinnon, J. Ashby, and K. T. Gottschall-Pass, “Feeding rats diets enriched in lowbuch blueberries for six weeks decreases ischemia-induced brain damage,” Nutritional Neuroscience, vol. 5, no. 6, pp. 427–431, 2002. View at Publisher · View at Google Scholar · View at Scopus
  91. J. Chang, A. Rimando, M. Pallas, et al., “Low-dose pterostilbene, but not resveratrol, is a potent neuromodulator in aging and Alzheimer's disease,” Neurobiology of Aging, vol. 33, no. 9, pp. 2062–2071, 2012.
  92. M. D. Matchett, S. L. MacKinnon, M. I. Sweeney, K. T. Gottschall-Pass, and R. A. R. Hurta, “Blueberry flavonoids inhibit matrix metalloproteinase activity in DU145 human prostate cancer cells,” Biochemistry and Cell Biology, vol. 83, no. 5, pp. 637–643, 2005. View at Publisher · View at Google Scholar · View at Scopus
  93. M. D. Matchett, S. L. MacKinnon, M. I. Sweeney, K. T. Gottschall-Pass, and R. A. R. Hurta, “Inhibition of matrix metalloproteinase activity in DU145 human prostate cancer cells by flavonoids from lowbush blueberry (Vaccinium angustifolium): possible roles for protein kinase C and mitogen-activated protein-kinase-mediated events,” The Journal of Nutritional Biochemistry, vol. 17, no. 2, pp. 117–125, 2006. View at Publisher · View at Google Scholar · View at Scopus
  94. V. C. Lin, Y. C. Tsai, J. N. Lin, et al., “Activation of AMPK by pterostilbene suppresses lipogenesis and cell-cycle progression in p53 positive and negative human prostate cancer cells,” Journal of Agricultural and Food Chemistry, vol. 60, no. 25, pp. 6399–6407, 2012.
  95. T. T. Y. Wang, N. W. Schoene, Y. S. Kim, C. S. Mizuno, and A. M. Rimando, “Differential effects of resveratrol and its naturally occurring methylether analogs on cell cycle and apoptosis in human androgen-responsive LNCaP cancer cells,” Molecular Nutrition and Food Research, vol. 54, no. 3, pp. 335–344, 2010. View at Publisher · View at Google Scholar · View at Scopus
  96. W. H. Fong, H. D. Tsai, Y. C. Chen, J. S. Wu, and T. N. Lin, “Anti-apoptotic actions of PPAR-γ against ischemic stroke,” Molecular Neurobiology, vol. 41, no. 2-3, pp. 180–186, 2010. View at Publisher · View at Google Scholar · View at Scopus
  97. W. G. Nelson, A. M. De Marzo, and W. B. Isaacs, “Prostate cancer,” The New England Journal of Medicine, vol. 349, no. 4, pp. 366–381, 2003. View at Publisher · View at Google Scholar · View at Scopus
  98. K. L. Wolfe, X. Kang, X. He, M. Dong, Q. Zhang, and R. H. Liu, “Cellular antioxidant activity of common fruits,” Journal of Agricultural and Food Chemistry, vol. 56, no. 18, pp. 8418–8426, 2008. View at Publisher · View at Google Scholar · View at Scopus
  99. D. M. Riche, C. L. McEwen, K. D. Riche, et al., “Analysis of safety from a human clinical trial with pterostilbene,” Journal of Toxicology, vol. 2013, Article ID 463595, 5 pages, 2013. View at Publisher · View at Google Scholar
  100. S. Hougee, J. Faber, A. Sanders et al., “Selective COX-2 inhibition by a Pterocarpus marsupium extract characterized by pterostilbene, and its activity in healthy human volunteers,” Planta Medica, vol. 71, no. 5, pp. 387–392, 2005. View at Publisher · View at Google Scholar · View at Scopus